In this study, we performed a comprehensive analysis of differentially methylated sites and gene expression patterns between children with SLE and healthy controls to investigate the potential of IFI44L gene methylation as a diagnostic biomarker for cSLE. The gene discussed is IFI44L; the disease is systemic lupus erythematosus.